| Brittany Lewis, LVN | |
|
912 N Hampton Rd Ste 105, Desoto, TX 75115-4012 | |
| (225) 733-7039 | |
| Not Available |
| Full Name | Brittany Lewis |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 912 N Hampton Rd Ste 105, Desoto, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487365086 | NPI | - | NPPES |
| 0000000 | Other | TX | 00000000 |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 00000000 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brittany Lewis, LVN 912 N Hampton Rd Ste 105, Desoto, TX 75115-4012 Ph: (225) 733-7039 | Brittany Lewis, LVN 912 N Hampton Rd Ste 105, Desoto, TX 75115-4012 Ph: (225) 733-7039 |
News Archive
Physicians at Washington University School of Medicine in St. Louis and Massachusetts General Hospital/Harvard Medical School in Boston have received a seven-year, $22 million grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health to help lead a multicenter clinical trial evaluating whether a novel immunosuppressant can reduce the risk of organ rejection after a lung transplant.
Robert B. Kiningham, MD, was awarded the Founders' Award at the 24th American Medical Society for Sports Medicine Annual Meeting in Hollywood, Fla. The award is bestowed when AMSSM leadership determines that a member exemplifies the best that a sports medicine physician can be and do.
Children in the San Fernando Valley now have access to an enhanced level of pediatric care, under the terms of an innovative agreement between Providence Tarzana Medical Center and Children's Hospital Los Angeles and its physicians.
CytoSen Therapeutics, a private biopharmaceutical company accelerating innovation in Natural Killer cell therapy, today announced it has received a favorable response from the U.S. Food and Drug Administration to its pre-Investigational New Drug meeting package for the proposed Phase 2 trial of CytoSen's adoptive NK cell therapy, CSTD002-NK, for the reduction of relapse in high risk acute myeloid leukemia or myelodysplastic syndrome in patients undergoing haploidentical hematopoietic stem cell transplantation.
Referred to as a "Beacon of Hope," Penn Medicine's new Pavilion, one of the largest hospital projects underway in the United States, opens to staff, patients, and visitors this month.
› Verified 8 days ago
Jacqueline Dorsey, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1020 Scotland Dr, 2009, Desoto, TX 75115 Phone: 469-245-9140 |